MENUNews Archive
Date: 09/13/2019
View a full schedule of U-M presentations: http://michmed.org/o4n7G Follow conference highlights on Twitter at @UMRogelCancer and @UmichRadOnc.
Date: 09/04/2019
The University of Michigan Rogel Cancer Center has named Evan T. Keller, D.V.M., Ph.D., associate director for shared resources.
Date: 09/03/2019
Breast cancer and/or ovarian cancer survivors should be offered genetic counseling and genetic testing for BRCA1 and BRCA2 genetic mutations, according to new recommendations from the U.S. Preventive Services Task Force.
Date: 08/29/2019
Christina Chapman, M.D. studies ways to improve equity in health care systems and the medical workforce to better meet the needs of the population.
Date: 08/26/2019
Since 2012, Michigan Drug Discovery has invested more than $2.3 million in more than 70 projects. Now, they are funding three projects led by Rogel Cancer Center researchers. Each project is looking to find new treatments for cancer.
Date: 08/24/2019
A clinical trial testing a new pancreatic cancer drug had promising initial results, say University of Michigan Rogel Cancer Center researchers in the Journal of Clinical Oncology. Investigators ran a phase 1 clinical trial that looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in repairing damaged DNA. The trial builds on almost 20 years of research at U-M focused on improving the treatment of pancreatic cancer cases that are too advanced for surgery.
Date: 07/31/2019
The University of Michigan Rogel Cancer Center continues to be ranked best in Michigan in the 2019-20 U.S. News & World Report “Best Hospitals” rankings, an honor that measures excellence in patient care.
Date: 07/24/2019
A new survey by researchers at the U-M Rogel Cancer Center and Institute for Healthcare Policy and Innovation suggests many patients are receiving the treatment when there’s no strong indication of benefit.
Date: 07/15/2019
A new way to cleanly separate out cancer cells from a blood sample enables comprehensive genetic profiling of the cancer cells, which could help doctors target tumors and monitor treatments more effectively.
Date: 07/15/2019
Large randomized clinical trials can uncover biomarkers to identify which cancer treatments are likely to work best for individual patients.